These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. A Multicenter Comparison of Carbapenem-Nonsusceptible Enterobacterales and Pseudomonas aeruginosa Rates in the US (2016 to 2020): Facility-Reported Rates versus Rates Based on Updated Clinical Laboratory and Standards Institute Breakpoints. Gupta V; Yu KC; Pogue JM; Watts JA; Clancy CJ Microbiol Spectr; 2022 Jun; 10(3):e0115822. PubMed ID: 35638777 [TBL] [Abstract][Full Text] [Related]
10. Performance Evaluation of the Newly Developed BD Phoenix NMIC-500 Panel Using Clinical Isolates of Gram-Negative Bacilli. Park BY; Mourad D; Hong JS; Yoon EJ; Kim D; Lee H; Jeong SH Ann Lab Med; 2019 Sep; 39(5):470-477. PubMed ID: 31037866 [TBL] [Abstract][Full Text] [Related]
11. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Tenover FC; Kalsi RK; Williams PP; Carey RB; Stocker S; Lonsway D; Rasheed JK; Biddle JW; McGowan JE; Hanna B Emerg Infect Dis; 2006 Aug; 12(8):1209-13. PubMed ID: 16965699 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic Performance of BD Phoenix CPO Detect Panels for Detection and Classification of Carbapenemase-Producing Gram-Negative Bacteria. Murata M; Kosai K; Akamatsu N; Matsuyama Y; Oda M; Wakamatsu A; Izumikawa K; Mukae H; Yanagihara K Microbiol Spectr; 2023 Jun; 11(3):e0089723. PubMed ID: 37162344 [TBL] [Abstract][Full Text] [Related]
13. Comparative Evaluation of Seven Tigecycline Susceptibility Testing Methods for Carbapenem-Resistant Li H; Zhou M; Chen X; Zhang Y; Jian Z; Yan Q; Liu WE Infect Drug Resist; 2021; 14():1511-1516. PubMed ID: 33907429 [TBL] [Abstract][Full Text] [Related]
14. Carbapenem susceptibility testing errors using three automated systems, disk diffusion, Etest, and broth microdilution and carbapenem resistance genes in isolates of Acinetobacter baumannii-calcoaceticus complex. Markelz AE; Mende K; Murray CK; Yu X; Zera WC; Hospenthal DR; Beckius ML; Calvano T; Akers KS Antimicrob Agents Chemother; 2011 Oct; 55(10):4707-11. PubMed ID: 21807971 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of three different methods for susceptibility testing of gentamicin in carbapenem resistant Enterobacterales. Cayci YT; Ulker KH; Birinci A Infez Med; 2021; 29(4):568-573. PubMed ID: 35146366 [TBL] [Abstract][Full Text] [Related]
17. Non-susceptibilities to antibiotics against important Gram-negative bacteria, and imipenem-relebactam, meropenem-vaborbactam against carbapenem non-susceptible Enterobacterales and Pseudomonas aeruginosa isolates implicated in complicated intra-abdominal and urinary tract infections in Taiwan, 2019. Jean SS; Lu MC; Ho MW; Ko WC; Hsueh PR; Int J Antimicrob Agents; 2022 Mar; 59(3):106521. PubMed ID: 35066144 [TBL] [Abstract][Full Text] [Related]
18. The importance of meropenem resistance, rather than imipenem resistance, in defining carbapenem-resistant Enterobacterales for public health surveillance: an analysis of national population-based surveillance. Ikenoue C; Matsui M; Inamine Y; Yoneoka D; Sugai M; Suzuki S; BMC Infect Dis; 2024 Feb; 24(1):209. PubMed ID: 38360618 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the BD Phoenix M50 Automated Microbiology System for Antimicrobial Susceptibility Testing with Clinical Isolates in Korea. Hong JS; Kim D; Kang DY; Park BY; Yang S; Yoon EJ; Lee H; Jeong SH Microb Drug Resist; 2019 Oct; 25(8):1142-1148. PubMed ID: 31161952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]